192 related articles for article (PubMed ID: 37067574)
21. Development of a headspace-solid phase microextraction gas chromatography-high resolution mass spectrometry method for analyzing volatile organic compounds in urine: Application in breast cancer biomarker discovery.
Li X; Wen X; Luo Z; Tian Y; Qian C; Zhang J; Ling R; Duan Y
Clin Chim Acta; 2023 Feb; 540():117236. PubMed ID: 36716910
[TBL] [Abstract][Full Text] [Related]
22. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines.
Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K
Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150
[TBL] [Abstract][Full Text] [Related]
23. Exhaled breath volatile biomarker analysis for thyroid cancer.
Guo L; Wang C; Chi C; Wang X; Liu S; Zhao W; Ke C; Xu G; Li E
Transl Res; 2015 Aug; 166(2):188-95. PubMed ID: 25666355
[TBL] [Abstract][Full Text] [Related]
24. Profiling allergic asthma volatile metabolic patterns using a headspace-solid phase microextraction/gas chromatography based methodology.
Caldeira M; Barros AS; Bilelo MJ; Parada A; Câmara JS; Rocha SM
J Chromatogr A; 2011 Jun; 1218(24):3771-80. PubMed ID: 21546028
[TBL] [Abstract][Full Text] [Related]
25. Early diagnosis of breast cancer from exhaled breath by gas chromatography-mass spectrometry (GC/MS) analysis: A prospective cohort study.
Zhang Y; Guo L; Qiu Z; Lv Y; Chen G; Li E
J Clin Lab Anal; 2020 Dec; 34(12):e23526. PubMed ID: 33150682
[TBL] [Abstract][Full Text] [Related]
26. Exhaled breath and oral cavity VOCs as potential biomarkers in oral cancer patients.
Bouza M; Gonzalez-Soto J; Pereiro R; de Vicente JC; Sanz-Medel A
J Breath Res; 2017 Mar; 11(1):016015. PubMed ID: 28165332
[TBL] [Abstract][Full Text] [Related]
27. Detection technologies of volatile organic compounds in the breath for cancer diagnoses.
Le T; Priefer R
Talanta; 2023 Dec; 265():124767. PubMed ID: 37327663
[TBL] [Abstract][Full Text] [Related]
28. Preliminary method for profiling volatile organic compounds in breath that correlate with pulmonary function and other clinical traits of subjects diagnosed with cystic fibrosis: a pilot study.
Woollam M; Siegel AP; Grocki P; Saunders JL; Sanders DB; Agarwal M; Davis MD
J Breath Res; 2022 Feb; 16(2):. PubMed ID: 35120338
[TBL] [Abstract][Full Text] [Related]
29. A rapid method for breath analysis in cystic fibrosis patients.
Kramer R; Sauer-Heilborn A; Welte T; Guzman CA; Höfle MG; Abraham WR
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):745-51. PubMed ID: 25431363
[TBL] [Abstract][Full Text] [Related]
30. Confounding effect of benign pulmonary diseases in selecting volatile organic compounds as markers of lung cancer.
Wang M; Sheng J; Wu Q; Zou Y; Hu Y; Ying K; Wan H; Wang P
J Breath Res; 2018 Sep; 12(4):046013. PubMed ID: 30102249
[TBL] [Abstract][Full Text] [Related]
31. Breathomics to diagnose systemic sclerosis using thermal desorption and comprehensive two-dimensional gas chromatography high-resolution time-of-flight mass spectrometry.
Zanella D; Guiot J; Stefanuto PH; Giltay L; Henket M; Guissard F; André B; Malaise M; Potjewijd J; Schleich F; Louis R; Focant JF
Anal Bioanal Chem; 2021 Jun; 413(14):3813-3822. PubMed ID: 33903944
[TBL] [Abstract][Full Text] [Related]
32. Investigation of lung cancer biomarkers by hyphenated separation techniques and chemometrics.
Buszewski B; Ulanowska A; Kowalkowski T; Cieśliński K
Clin Chem Lab Med; 2011 Oct; 50(3):573-81. PubMed ID: 22035139
[TBL] [Abstract][Full Text] [Related]
33. Ultrafast gas chromatography coupled to electronic nose to identify volatile biomarkers in exhaled breath from chronic obstructive pulmonary disease patients: A pilot study.
Rodríguez-Aguilar M; Ramírez-García S; Ilizaliturri-Hernández C; Gómez-Gómez A; Van-Brussel E; Díaz-Barriga F; Medellín-Garibay S; Flores-Ramírez R
Biomed Chromatogr; 2019 Dec; 33(12):e4684. PubMed ID: 31423612
[TBL] [Abstract][Full Text] [Related]
34. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
35. Identifying potential breath biomarkers for early diagnosis of papillary thyroid cancer based on solid-phase microextraction gas chromatography-high resolution mass spectrometry with metabolomics.
Li L; Wen X; Li X; Yan Y; Wang J; Zhao X; Tian Y; Ling R; Duan Y
Metabolomics; 2024 May; 20(3):59. PubMed ID: 38773019
[TBL] [Abstract][Full Text] [Related]
36. Organic metabolites in exhaled human breath--a multivariate approach for identification of biomarkers in lung disorders.
Gaspar EM; Lucena AF; Duro da Costa J; Chaves das Neves H
J Chromatogr A; 2009 Apr; 1216(14):2749-56. PubMed ID: 19036381
[TBL] [Abstract][Full Text] [Related]
37. Development of an Exhaled Breath Monitoring System with Semiconductive Gas Sensors, a Gas Condenser Unit, and Gas Chromatograph Columns.
Itoh T; Miwa T; Tsuruta A; Akamatsu T; Izu N; Shin W; Park J; Hida T; Eda T; Setoguchi Y
Sensors (Basel); 2016 Nov; 16(11):. PubMed ID: 27834896
[TBL] [Abstract][Full Text] [Related]
38. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
39. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive two-dimensional gas chromatographic platforms comparison for exhaled breath metabolites analysis.
Zanella D; Henin A; Mascrez S; Stefanuto PH; Franchina FA; Focant JF; Purcaro G
J Sep Sci; 2022 Sep; 45(18):3542-3555. PubMed ID: 35853166
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
